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Epigenetics is the study of heritable changes in gene expression that occur without a
change in DNA sequence. Cancer is a multistep process derived from combinational
crosstalk between genetic alterations and epigenetic inﬂuences through various environ-
mental factors. The observation that epigenetic changes are reversible makes them an
attractive target for cancer prevention. Until recently, there have been difﬁculties studying
epigenetic mechanisms in interactions between dietary factors and environmental toxi-
cants.The development of the ﬁeld of cancer epigenetics during the past decade has been
advanced rapidly by genome-wide technologies – which initially employed microarrays but
increasingly are using high-throughput sequencing – which helped to improve the quality
of the analysis, increase the capacity of sample throughput, and reduce the cost of assays.
It is particularly true for applications of cancer epigenetics in epidemiologic studies that
, examine the relationship among diet, epigenetics, and cancer because of the issues of
tissue heterogeneity, the often limiting amount of DNA samples, and the signiﬁcant cost
of the analyses. This review offers an overview of the state of the science in nutrition,
environmental toxicants, epigenetics, and cancer to stimulate further exploration of this
important and developing area of science. Additional epidemiologic research is needed to
clarify the relationship between these complex epigenetic mechanisms and cancer.
Keywords: cancer, epigenetics, diet, nutrient, toxicants
INTRODUCTION
Cancer represents a group of diseases initiated and driven
largely by heritable genetic aberrations resulting from expo-
sure to endogenous and environmental agents (Loeb and Harris,
2008; Pogribny et al., 2009). Therefore, the general approach
for elucidating key events in cancer development has focused
on identifying genetic aberrations associated with carcinogene-
sis. However, the presence of genetic lesions alone is not suf-
ﬁcient for tumor formation. Tumor formation results mainly
from the inability of cells to maintain and control accurate
expression of genetic information. Additionally, genetic alter-
ations alone cannot explain the extremely diverse phenotypic
changes observed in preneoplastic and malignant cells. These
ﬁndings have led to the hypothesis that the transition from
promotion – a stage that may be reversible in carcinogenesis –
to progression – a stage that may be irreversible – could be
driven primarily by epigenetic abnormalities (Pitot, 2007). The
term “epigenetics” refers to mechanisms outside of the scope of
conventional genetics. Epigenetics is deﬁned as processes that
regulate heritable changes in gene expression that are trans-
mitted through meiosis and mitosis, without any modiﬁca-
tion of the primary DNA sequence. These epigenetic mecha-
nisms include DNA methylation and a complex set of histone
modiﬁcations, including acetylation, methylation, phosphoryla-
tion, ADP-ribosylation, and ubiquitination, leading to chromatin
remodeling.
Diet and lifestyle play a crucial role in cancer etiology. It
has been estimated that more than one-third of cancer deaths
in the United States potentially can be avoided through dietary
modiﬁcation (Doll andPeto,1981).Differentmechanisms, includ-
ing antioxidant, anti-inﬂammatory, and anti-estrogenic processes,
have been proposed to explain the protective nature of certain
dietary components. However, the exact mechanistic pathways in
which these effects are exerted on cells to avoid, delay, or reverse
carcinogenesis are not as clear. Epigenetic marks are inﬂuenced
by aging and environmental exposures, including dietary intakes
(Issa et al., 1994; Issa, 2003). Emerging evidence indicates that
nutrition and environmental factors affect epigenetic changes. The
observation that epigenetic changes are reversible makes them an
attractive target for cancer prevention. The intent of this review
is to provide an overview of the state of the science in nutri-
tion, environmental toxicants, epigenetics, and cancer to stimulate
the continuous exploration of how nutritional factors and envi-
ronmental toxicants in foods affect the functioning of genes via
molecular mechanisms other than those observed in conventional
genetics, such as mutations and polymorphisms.
DNA METHYLATION
The most well-known epigenetic mechanism is methylation. DNA
methylation is a major epigenetic phenomenon that predomi-
nantly involves the covalent addition of a methyl group (CH3)
to the 5′-position of cytosine that precedes a guanosine in the
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DNAsequence (theCpGdinucleotides), thereby regulating genetic
expression and integrity in various biological processes, such as
differentiation, genomic imprinting, DNA mutation, and DNA
repair (Fang et al., 2007). This is referred to as an epigenetic
modiﬁcation because it does not change the coding sequence of
the DNA. The CpG dinucleotides are not distributed evenly in
the whole genome, but tend to be clustered in small stretches of
DNA termed “CpG islands” (Robertson and Wolffe, 2000). These
regions often are associated with the promoter regions of genes.
Approximately one-half of the genes in the human genome have
such CpG-rich promoter regions (Herman and Baylin, 2003). A
majority of the CpG dinucleotides in the human genome that
are not associated with CpG islands are heavily methylated (Her-
man and Baylin, 2003). On the other hand, the dinucleotides
in CpG islands, in particular those associated with gene pro-
moters, usually are unmethylated (Bird, 2002). Patterns of DNA
methylation are generated during development involving de novo
methylation and demethylation activities. DNA methylation is an
enzymatic process that is mediated by DNA methyltransferases
(DNMTs). DNMT3 regulates de novo methylation during devel-
opment, whereas DNMT1 maintains DNA methylation patterns
during cell replication. The genome methylation pattern is pre-
cisely inherited during mitosis and is highly tissue speciﬁc. Cyto-
sine methylation changes the structure of the major groove in the
DNA molecule and disrupts the attachment of DNA-binding pro-
teins and transcription factors. Genes methylated at speciﬁc sites,
such as upstream of a promoter region, are either not transcribed
into messenger RNA (mRNA) or are transcribed at a reduced rate,
thus reducing translation of the gene into the encoded protein. As
a result, epigenetic DNA methylation contributes to the control of
gene and ultimately protein expression (Costello and Plass, 2001;
Duthie, 2011). It can induce the gene to turn on or off, and to up-
or down-regulate.
Aberrant DNA methylation patterns in cancer cells have been
recognized for decades (Boehm and Drahovsky, 1983). However,
the interpretation of observed DNA methylation and cancer risk
remains a challenge because virtually all types of cancer that have
been examined have shown both global hypomethylation and
gene-speciﬁc hypermethylation in gene promoter regions (Baylin
et al., 1998).Hypermethylation of promoter regions,which is asso-
ciated with transcription silencing, similar to DNA mutation, has
been proposed as a mechanism for tumor suppressor gene inac-
tivation in human cancers (Jones and Baylin, 2007). In addition,
a number of candidate tumor suppressor genes, such as HIC1,
INK4b (p15), TIMP3, and others that are not commonly inacti-
vated by mutation, are transcriptionally silenced by methylation.
The aberrant methylation of genes that suppress tumorigene-
sis appears to occur early in tumor development, accumulates
progressively, and eventually leads to the malignant phenotype
(Fearon and Vogelstein, 1990; Davis and Uthus, 2004). Hyperme-
thylation has been found to be associated with the dysregulation
of pathways involved in the cancer process, such as DNA repair
(hMLH1, BRCA1, MGMT ), cell-cycle regulation (p16, p14, p15),
carcinogenmetabolism (GSTP1), apoptosis (DAPK,APAF-1),hor-
monal response (RARβ2), and cell adherence (CDH1, CDH3;
Costello and Plass, 2001;Momparler, 2003;Davis andUthus, 2004;
Esteller, 2008).
HISTONE MODIFICATIONS AND THE HISTONE CODE
A complex of DNA and globular proteins, known as “histones,”
package heritable genetic information in eukaryotic nuclei in
the form of nucleosomes that constitute chromatin. Nucleo-
somes are composed of 147 bp of DNA wrapped around core
histone proteins named H2A, H2B, H3, and H4. An additional
histone, H1, is located at the outer surface of the nucleosome
to anchor DNA to the nucleosome. H3 and H4 have long tails
that extend out from the nucleosome and can be modiﬁed chem-
ically by acetylation, methylation, ubiquitination, phosphoryla-
tion, sumoylation,citrullination,andADP-ribosylation (Baccarelli
and Bollati, 2009). These chemical modiﬁcations can result in
a closed chromatin conformation that suppresses transcription,
or in an open conformation that activates transcription. The
most common modiﬁcations are acetylation and methylation
on histone lysine residues. Increased acetylation results in tran-
scription activation, and methylation of histones can result in
either repression or activation of transcription, as determined
by the lysine residue position involved (Bollati and Baccarelli,
2010).
Growing lists of histone modiﬁcations, histone-modifying
complexes, and their interactions have been developed into what
is commonly referred to as a “histone code.”Together with methy-
lation, the histone code ensures that chromatin exists in a tran-
scriptionally inactive mode that undergoes activation of speciﬁc
gene regions when needed. The timely on/off switching of genes
requires relevant changes in the epigenetic proﬁle. Given that
chromatin transcriptional activity is related to germline develop-
ment, X-inactivation, stem-cell identity, cell-cycle regulation, and
mitosis/meiosis, the decoding of epigenetic mechanisms should
hold insights for studying cancer (Delage and Dashwood, 2008).
When histone modiﬁcations and chromatin remodeling processes
become deregulated, they could result in mutations in oncogenes,
tumor suppressor genes, or DNA repair genes. Such changes then
could result in genomic instability, oncogenic transformation, and
the development of cancer. Histone modiﬁcations are extremely
dynamic and highly regulated. When histone-modifying com-
plexes, including histone acetyltransferases (HATs), deacetylases,
or histone methyltransferases, display aberrant activity, cancer
development by misregulation of chromatin structure and activ-
ity may occur, as happens frequently in human leukemia (Herceg,
2007).
Histone acetylation typically results in an open chromatin con-
ﬁguration that facilitates transcription factor access to DNA and
gene transcription. It also can silence tumor suppressor genes in
cancer cells if deacetylated (Wade,2001;Nian et al.,2009).HATs are
responsible for acetylation; whereas histone deacetylases (HDACs)
are responsible for histone deacetylation. Overexpression and or
increased activity of HDACs is found in many malignancies, and
the repression of transcription can result in dysregulated cell-
cycle kinetics, apoptosis, and differentiation (McLaughlin and La
Thangue,2004;Dokmanovic andMarks,2005;Mariadason,2008).
Many dietary components, such as sulforaphane, a major compo-
nent in cruciferous vegetables, have shown promising results in
direct or indirect inhibition of HDAC activity as well as other
histone modiﬁcation activities in cancer prevention and therapy
(Myzak et al., 2004; Meeran et al., 2010).
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RNA INTERFERENCE
RNA interference plays an important role in controlling the activ-
ity level of speciﬁc genes. One type of small RNA molecule
involved in RNA interference is microRNA (miRNA). miRNAs
are single-stranded non-coding RNAs of approximately 21–23
nucleotides in length whose main function is to down-regulate
gene expression by interfering with mRNA processes. miRNA sup-
presses gene expression by affecting mRNA stability, targeting the
mRNA for degradation, or both (Mathers et al., 2010). In lim-
ited cases, miRNA also may increase gene transcription (Barros
and Offenbacher, 2009). Close to 1,000 miRNAs have been iden-
tiﬁed in human cells with the potential to regulate the expression
of about one-third of human mRNAs and inﬂuence almost all
genetic pathways through their effects on transcription factors,
receptors, and transporters (Esquela-Kerscher and Slack, 2006).
miRNAs have an established repressing role in cancer initiation,
development, maintenance, and proliferation (Esquela-Kerscher
and Slack, 2006). Mutation or mis-expression of miRNA occurs
in several human cancers, and miRNAs have been reported to
repress the expression of cancer-related genes. Taken together,
these twoobservations suggest the potential importance of miRNA
in tumorigenesis (Esquela-Kerscher and Slack, 2006). It has been
demonstrated that chemopreventive agents, such as n−3 polyun-
saturated fatty acid, pectin, folate, retinoids, and curcumin, favor-
ablymodulate carcinogen-directed non-codingmiRNA signatures
in various cancer (Kutay et al., 2006; Sun et al., 2008; Wang et al.,
2008; Davidson et al., 2009; Shah et al., 2011). These data sug-
gest a persistent effect of diet in miRNA-mediated oncogenic
transformation.
CHROMOSOMAL INSTABILITY
The stability of the genome in general and chromosomes in partic-
ular plays a large role in several diseases including cancer. Mecha-
nisms by which stability is undermined include DNA metabolism
and repair gene silencing by aberrant methylation near CpG pro-
moter regions, and accelerated telomere shortening. Nutritional
factors may control both mechanisms. For example, zinc and
magnesium levels help determine the effectiveness of DNA repair
and DNA metabolism, respectively, and telomere length may be
associated with folate and nicotinic acid levels (Bull and Fenech,
2008).
TRANSPOSONS
Transposable elements are sequences of DNA that move to new
positions within the genome of a single cell. Transposons are
among several types of transposable elements which include plas-
mids, bacteriophages, and certain introns (Wicker et al., 2007).
Transposons can behave as mutagens that cause genomic damage
by various pathways. For example a given section of DNA could
be cut and pasted into another DNA region potentially resulting
in disruption of the functional gene it was pasted into or leav-
ing behind an irreparable gap in the gene it was cut from, both
resulting in a mutagenic effect. In other cases multiple sequences
of pasted copies result which disturb chromosomal pairing dur-
ing mitosis and meiosis. Some human blood dyscrasias can be
caused by transposons including hemophilia A and B and por-
phyria (Kazazian, 2004). Eukaryotic cells use RNA interference
to silence transposable elements immediately after they are tran-
scribed thereby inhibiting transposon activity levels to protect
against genomic damage.
LOSS OF IMPRINTING
Imprinting is a process in which genes are silenced, depend-
ing on whether they are maternal or paternal in origin. The
epigenome cycles through a series of precisely timed methylation
changes designed to ensure proper development, both in utero
and throughout life, of the organism. In humans, the paternal
genome is actively demethylated, and the maternal genome is
passively demethylated following fertilization (Bernal and Jirtle,
2010). Genomic imprinting results in parent-of-origin-dependent
monoallelic expression of a subset of critical autosomal genes
(Murphy and Jirtle, 2003). Loss of methylation can either shut
down these critical genes or lead to overexpression of the gene
product. Because of their monoallelic expression, imprinted genes
are particularly susceptible to dysregulated expression that results
from epigenetic aberrations. Environmental exposures that alter
the imprinting of these geneswill lead to enhanced susceptibility to
disease (Das et al., 2009). For example, a study has demonstrated
that loss of imprinting at the insulin-like growth factor 2 (igf2)
locus could be induced by synthetic methyl-donor-deﬁcient post
weaning diet in mice (Waterland et al., 2006). Loss of imprinting is
associated speciﬁcally with hypomethylation in colon cancer (Cui
et al., 2002).
EFFECTS OF NUTRITION ON EPIGENETICS
Established epigenetic patterns during the fetal period can be
changed in adult life by environmental factors, including nutri-
tion. Diet can profoundly alter epigenetic patterns in animals.
The Agouti mouse has been used extensively to demonstrate the
impact of maternal nutrition on the fetal epigenome and the phe-
notype of the offspring (Wolff et al., 1998). Coat color is linked
to the methylation status of the Agouti gene, which is highly
dependent on maternal diet. Most importantly, altered epigenetic
patterns are associated with the increased risk of diabetes-like con-
ditions, obesity, and tumorigenesis (Yen et al., 1994;Dolinoy, 2008;
Duthie, 2011). Evidence also suggests that speciﬁc nutrients in the
human diet that are strongly associated with risk of cancer can
modulate DNA methylation (Kim et al., 2009). For example, a
study found that identical twins possess the same genotype and
no distinguishable epigenetic differences in their early life, but
remarkable differences were found in genomic methylation and
histone acetylation patterns later in their life (Fraga et al., 2005).
These epigenetic differencesmay result in different gene expression
and disease susceptibility.
Nutrient intakes have been found to play an important role in
regulating one-carbon metabolism (Davis and Uthus, 2004; Lee
et al., 2005). Excessive or deﬁcient nutrient status may have an
effect on DNA methylation. This is based on the observation that
the primary methyl-donor, S-adenosylmethionine (SAM),may be
regenerated from S-adenosylhomocysteine (SAH) through a series
of chemical reactions that rely on the presence of several nutrients,
such as folate, betaine, choline, zinc, vitamin B6, and vitamin B12,
as cofactors or intermediates. As shown in Figure 1, the metabo-
lism of folate, choline, betaine, and methionine are interrelated.
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FIGURE 1 | Overview of the methionine–homocysteine–folate-B12 cycle, which provides methyl donors for methyltransferase. Nutritional regulations of
the cycle are identiﬁed by rectangle frames. (Adopted from Delage and Dashwood, 2008).
They interact at the point in the cycle where homocysteine is
converted to methionine, and therefore, the metabolites of these
nutrients have critical roles in forming SAM, known as the uni-
versal methyl-donor. In a set of reactions necessary for the normal
functioning of cells, SAM donates its methyl group in methylation
reactions, including the methylation of DNA, RNA, and protein.
Deﬁciency of any of these nutrients can result in a depletion of
cellular pools of SAM, which may cause aberrant DNA methy-
lation (Gilbert and Liu, 2010). Other dietary factors, including
alcohol, arsenic, cadmium, coumestrol, equol, genistein, nickel,
selenium, tea polyphenol, vitamin A, and zinc, also are known to
inﬂuence DNA methylation and cancer susceptibility (Davis and
Uthus, 2004).
Literature that explores possible nutritional effects on histone
regulation is scarce (Mathers et al., 2010). Butyrate, a product
of carbohydrate fermentation, has been shown to inhibit certain
histone deacetylases. The status and function of acetyl trans-
ferases and acetylation/deacetylation of histones can be affected by
organosulfur compounds from garlic, isothiocyanates from cru-
ciferous vegetables, and compounds such as resveratrol found in
grapes (Delage and Dashwood, 2008). These bioactive food com-
ponents also have been shown to alter epigenetic processes in cell
functions, such as control of proliferation, upregulated apoptosis,
and reduction in inﬂammation (Ross et al., 2008). Additionally,
changes in miRNA expression in response to dietary exposure
may mediate effects on cancer risk. Emerging evidence indicates
that awide range of dietary factors, including bothmacronutrients
(fat, protein, and alcohol) and micronutrients (folate and vitamin
E), alter the expression of many miRNAs in rodents and humans
(Marsit et al., 2006b). Marsit et al. (2006a) reported that both
folate deﬁciency and arsenic exposure resulted in a global increase
in miRNA expression in the human immortalized lymphoblastoid
cell line TK-6.
MATERNAL NUTRITION AND EPIGENETICS
Amother’s diet is passedon toher fetus and affects fetal growth and
development. The fetal origins of disease hypothesis, also known
as Barker’s hypothesis, essentially proposes that under-nutrition
during gestation increases the risk of disease later in life (Barker,
2007). Barker et al. (1989) published data showing that men with
the lowest weights at birth and at 1 year had the highest death
rates from ischemic heart disease, and increasing weight was asso-
ciated with a graded decrease in the risk. The authors proposed
that an environment that induces poor fetal and infant growth will
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be followed by high risk of ischemic heart disease in adulthood.
This idea has been validated in several prospective cohort stud-
ies. For example, in Sweden (Leon et al., 1998), Finland (Forsén
et al., 1997), Denmark (Baker et al., 2008), Norway (Risnes et al.,
2009), England (Syddall et al., 2005), and Scotland (Lawlor et al.,
2005), mortality from ischemic heart disease was inversely associ-
ated with birth-weights. In the United States (Rich-Edwards et al.,
1997, 2005) and India (Stein et al., 1996), a strong inverse associ-
ation between birth weight and non-fatal coronary heart disease
was reported. A recent systematic review of 17 published studies
concluded that the ﬁndings are consistent with low birth-weights
increasing risk for ischemic heart disease (Huxley et al., 2007).
If early life exposures indeed affect cardiovascular disease (CVD)
risk, by logical extension they also may affect cancer risk because
some of the biological risk factors for CVD, such as abnormalities
in lipid metabolism and non-insulin-dependent diabetes mellitus,
also can affect cancer risk.
Establishing a clear link between maternal diet and epigenetic
states of the genome would require a highly sensitive phenotypic
outcome. This evidence is not only available but very convincing
from the viable yellow agouti (Avy) mouse model. The wild-type
murine Agouti gene encodes a paracrine signaling molecule that
produces either black eumelanin (a) or yellow pheomelanin (A)
(pigment in the hair follicles). Transient A expression in hair fol-
licles during a speciﬁc stage of hair growth results in a sub-apical
yellow band on each black hair shaft, causing the brown agouti
coat color of wild-type mice (Duhl et al., 1994). Wolff et al. (1998)
were the ﬁrst to demonstrate that feeding pregnant black a/a dams
a methyl-supplemented diet shifts the coat color distribution of
their Avy offspring. As it became evident that Avy/a coat color cor-
relates with Avy methylation status (Morgan et al., 1999), it was
argued that maternal methyl-donor diets change the coat color of
the offspring via Avy methylation (Cooney et al., 2002). However,
Waterland and Jirtle (2003) were able to demonstrate that dietary
supplementation of viable yellow Agouti (Avy) mice during preg-
nancy with methyl donors (folic acid, vitamin B12, choline, and
betaine) alters the coat color of their offspring because of the
increased DNA methylation of a transposable element upstream
of the Agouti gene, rather than mutation of the gene. When a
mouse’s agouti gene is completely unmethylated it has a yellow
coat color, is obese and prone to diabetes and cancer. When the
agouti gene is methylated (as it is in normal mice) the coat color
is brown and the mouse has a low disease risk. These observations
provide clues that epigenetic modiﬁcations resulting from dietary
effects may have long-term health consequences. Early life epige-
netic alteration could, for example, contribute to carcinogenesis
that is known to be affected by dietary intake.
POTENTIAL APPLICATION TO REVERSE EPIGENETICS
CHANGES
Although epigenetic changes are heritable in somatic cells, the
notion that these modiﬁcations are also potentially reversible as
observed through the ﬁnding of Agouti mouse model makes them
attractive and promising avenues for tailoring cancer preventive
and therapeutic strategies (Link et al., 2010). It is thus thought
that certain adverse epigenetic modiﬁcations as the results of
environmental and dietary exposure may be modulated. Many
studies, both animal and human, had been exploring the poten-
tial reversible characteristics of epigenetic changes since the initial
ﬁndings from Agouti model. For example, signiﬁcant increases
in both Igf2 and H19 expression were found in the prostate tis-
sues in mice fed with choline–methionine deﬁcient diet prostate
compared to controls. These expression changes were reversible
with shorter exposure to the choline–methionine deﬁcient diet
(Dobosy et al., 2008). A randomized feeding study of low birth
weight and normal birth weight young men showed that low
birth weight subjects developed peripheral insulin resistance and
reduced PPARGC1A and OXPHOS gene expression after 5 days
of high-fat overfeeding (Brons et al., 2010). However, PPARGC1A
methylation increased in only normal birth weight subjects after
overfeeding in a reversible manner. This is the ﬁrst study demon-
strated in human that DNA methylation induced by overfeeding
is reversible. Most recently, a primate study reported that expo-
sure to a maternal high-fat diet in utero signiﬁcantly alters the
expression of fetal hepatic Npas2 compared with that in control
diet-exposed animals (Suter et al., 2011). It is reversible in fetal off-
spring from obese dams reversed to a control diet. Although the
Npas2 promoter remains largely unmethylated, differential Npas2
promoter occupancy of acetylation of fetal histone H3 at lysine
14 (H3K14ac) occurs in response to maternal high-fat diet expo-
sure compared with control diet-exposed animals. In addition,
disruption of Npas2 is found to be consistent with high-fat diet
exposure in juvenile animals, regardless of in utero diet exposure.
The ﬁndings suggest that peripheral Npas2 expression is uniquely
vulnerable to diet exposure.
EFFECTS OF ENVIRONMENTAL TOXICANTS ON EPIGENETICS
The effect of several nutrients, such as folate, vitamin
B12, vitamin B1, polyphenols, ﬂavonoids, phytoestrogens, sul-
foraphane/isothiocyanates, vitamin A, fat, and selenium, and
dietary components, such as butyrate, biotin, lipoic acid, garlic
organosulfur compounds, and vitamin E metabolites, on epige-
netics have been reviewed to some extents (Dashwood et al., 2006;
Barnett et al., 2010;Chen andXu,2010;Mathers et al., 2010; vel Szic
et al., 2010; Duthie, 2011; McKay and Mathers, 2011).. However,
the epigenetic effect of environmental toxicants consumed along
with foods on diseases, such as cancer has not been systematically
examined. Therefore, this review will focus on the environmental
toxicant exposures through dietary intake.
FOOD AS A VEHICLE FOR ENVIRONMENTAL TOXICANTS
Environmental toxicants are found naturally in foods or may be
introduced by way of cooking practices, production processes, or
pesticide exposure.Many environmental toxicants introduced into
food either naturally or anthropogenically are heavy metals and
endocrine disruptors. These ingested toxicants have been linked
to modulations in epigenetic pathways and increased disease
susceptibility.
ENVIRONMENTAL TOXICANTS AND EPIGENETICS
Epidemiological and experimental studies link epigenetic modu-
lations with both nutritional factors and environmental toxicants
(Feil, 2006; Baccarelli and Bollati, 2009). Nutrition and envi-
ronmental toxicants affect epigenetic pathways mainly through
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DNA methylation and complex histone modiﬁcations. Evidence
linking nutritional and environmental factors with DNA hyper
or hypomethylation provides the most compelling support for
such an association (Mathers et al., 2010). Further, nutrition may
modulate the toxicity of environmental pollutants, through either
synergistic or antagonistic effects (Hennig et al., 2007). Environ-
mental toxicants also may cause aberrant modiﬁcations in the
metabolic activity of nutritional factors (Hennig et al., 2004). The
relationship between nutrition and environmental toxicants and
epigenetic modulations is complex, however, and an exact causal
relationship has yet to be identiﬁed. In addition, the complexity
of the relationship is compounded by the interaction of multi-
ple toxicants and dietary factors. Nonetheless, nutritional factors
and environmental toxicants may affect similar biological and
epigenetic pathways and thus should be examined simultaneously.
ARSENIC
Arsenic occurs naturally in the earth’s crust with higher con-
centrations in some geographic areas. Arsenic is usually found
combined with other elements. When combined with elements
other than carbon, it is called “inorganic arsenic.” Arsenic and
inorganic arsenic compounds can be emitted into air and then
deposited into water and soil during industrial operations such as
ore mining and smelting, and during volcanic eruptions and forest
ﬁres (U.S. Environmental Protection Agency, 2007). Arsenic (As)
and inorganic arsenic compounds are established carcinogens that
have been linked to cancers of the skin, bladder, liver, lung, and
prostate (IARC, 2004). Arsenic is ubiquitous in the environment
and can contaminate air, food, and water, with more than 137
million people in more than 70 countries having been exposed
(Bagchi, 2007). In fact, the major source of human exposure is
throughdrinkingwater fromcontaminatedwell sources. Exposure
usually occurs in the form of arsenite or arsenate, with exposure
to inorganic arsenite being more toxic (Salnikow and Zhitkovich,
2008). Those not exposed to arsenic through drinking water may
be exposed by consuming rice products (Dwivedi et al., 2010; Tuli
et al., 2010). Khan et al. (2010) recently investigated the mecha-
nisms by which arsenic may enter the food chain in Bangladesh
and found that arsenic and cadmium were present throughout
the food chain, and that cooking practices may inﬂuence arsenic
levels in food. Their results showed that the presence of arsenic in
food decreased the uptake of essential nutrients such as iron,man-
ganese, copper, and zinc (Khan et al., 2010). High levels of arsenic
also are found in ﬁsh and shellﬁsh, though this exposure usually
is in the organic non-toxic form. As with many chemicals, the
absorption of arsenic can be modulated by nutritional status (Li
et al., 2008). Thus, malnourished individuals, especially children,
may be more susceptible to increased arsenic exposure levels.
The mechanisms of arsenic’s carcinogenicity remain unclear.
Arsenic is thought to exert its carcinogenic effect by inducing DNA
hypomethylation, leading to aberrant gene expression (Zhao et al.,
1997;Verma and Srivastava, 2002), or by DNA methylation silenc-
ing genes associated with controlling tumorigenesis (Verma and
Srivastava, 2002; Vaissière et al., 2008). Consequently, exposure to
arsenic has been associated with DNA hypo and hypermethylation
(Salnikow and Zhitkovich, 2008). Global DNA hypomethylation
has been observed in vitro in animal studies and is thought to
result from the depletion of SAMand repressed expression of DNA
methyltransferase genes DNMT1 and DNMT3A (Reichard et al.,
2007). Zhao et al. (1997) found evidence of low SAM, decreased
methyltransferase activity, and global DNA hypomethylation in
rat liver epithelial cells that were chronically exposed to arsenic. A
reduction in DNA methylation also has been observed in human
cell lines. For example, globalDNAhypomethylationwas observed
in HaCaT keratinocytes exposed to low-level arsenic (Reichard
et al., 2007). Normal human prostate cells were malignantly trans-
formed after chronic low-level arsenic exposure, and the trans-
formed cells showed evidence of genomic DNA hypomethylation
(Coppin et al., 2008) and K-ras overexpression (Benbrahim-Tallaa
et al., 2005). Although arsenic exposure led to the overexpression
of K-ras, therewas no evidence of hypomethylation in its promoter
region.
Relatively few studies that utilize human subjects have investi-
gated the association of arsenic with epigenetic changes. Arsenic
in drinking water was associated with genomic hypomethylation
of peripheral blood leukocytes (PBL), and the association was
stronger among individuals with higher folate concentrations (Pil-
sner et al., 2007). These researchers later observed that individuals
with hypomethylated PBL DNA had an increased risk of develop-
ing skin lesions (Pilsner et al., 2009). Also, hypermethylation of
the promoter region of the p53 gene in a dose–response fashion
was observed in DNA arsenic-exposed individuals and individ-
uals with arsenic-induced skin cancer (Chanda et al., 2006). In
a population-based case study of incident bladder cancer, arsenic
exposure was associatedwith hypermethylation of tumor suppres-
sor genes RASSF1A and PRSS3 (Marsit et al., 2006a). In addition,
hypermethylation in the promoter region of DAPK was found in
bladder cancers among individuals in arsenic-contaminated areas
(Chen et al., 2007). Although most studies that have examined the
epigenetic effects of arsenic have focused on DNA methylation,
investigations into altered histone modiﬁcation associated with
arsenic-induced gene expression and carcinogenesis are under way
(Vaissière et al., 2008; Zhou et al., 2008).
CADMIUM
Cadmium (Cd) occurs naturally in the earth’s crust and also can
be introduced into the environment by human activities such as
coal burning and manufacturing. Cadmium and cadmium com-
pounds are carcinogenic to animals and humans (IARC, 1993;
National Toxicology Program, 2005). Air, water, and soil are
sources of cadmium exposure, and exposure routes for humans
include ingestion, dermal contact, and inhalation. The primary
source of cadmium exposure in the general population is through
contaminated food (ATSDR, 2008). Fish and shellﬁsh may accu-
mulate high levels of cadmium from aquatic environments and
often are thought to be the biggest contributors to cadmium
toxicity (Perello et al., 2008). Plants may absorb high levels of cad-
mium from contaminated soils. Cadmium-contaminated plants
ﬁrst were discovered to cause human toxicity in the 1950s (Kaneta
et al., 1986).
Cadmium appears to mimic zinc and calcium, is rapidly
cleared from the blood, and concentrates in several tissues, includ-
ing the liver and kidney (Waalkes, 2003). The main source of
epidemiologic evidence of the association between cadmium
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exposure and human cancer comes from occupational studies of
workers involved in the manufacture of nickel–cadmium batteries
and electroplating processes. Cadmium exposure has been associ-
ated with lung cancer (Beveridge et al., 2010) in a dose–response
manner (Stayner et al., 1992). Cadmium also has been associated
with prostate, pancreas, renal, liver, stomach, and bladder cancers
(Waalkes, 2003). Mechanisms of cadmium carcinogenicity involve
the production of oxidative stress, aberrant gene activation and
signal transduction, disruption of DNA repair, and suppressed
apoptosis (Waisberg et al., 2003).
Cadmium is weakly mutagenic, leading some to believe that
its mechanism for carcinogenesis has non-genotoxic or epige-
netic components (Takiguchi et al., 2003; Waalkes, 2003; Waisberg
et al., 2003; Jiang et al., 2008). Evidence has indicated that acute
exposure (1week) of TRL1215 rat liver cells in vitro to cadmium
increased DNA hypomethylation and reduced DNMT activity,
whereas more prolonged exposure (10weeks) led to increased
global hypermethylation and enhancedDNMTactivity (Takiguchi
et al., 2003). This result was replicated in human embryo lung
ﬁbroblast cells in which long-term, low-dose exposure increased
DNA methylation and DNA methyltransferase activity; but also
upregulated mRNA levels of DNMT1, DNMT3a, and DNMT3b,
but at higher concentrations (Jiang et al., 2008). Cadmium expo-
sure induced the malignant transformation of prostate epithelial
cells and led to overexpression of DNMT3b without changes
in DNMT1expression. Importantly, DNMT3b activity was an
early event and occurred before the cells were malignantly trans-
formed (Benbrahim-Tallaa et al., 2007). Promoter regions of
tumor suppressor genes RASSF1A and p16 were heavily methy-
lated and downregulated at about the same time that DNMT3b
overexpression ﬁrst occurred.
NICKEL
Nickel (Ni) compounds are classiﬁed as carcinogenic to humans,
and metallic nickel possibly is carcinogenic to humans (IARC,
1990). Nickel is used in industrial processes to produce stainless
steel, copper–nickel alloys, electroplating, alkaline batteries, coins,
welding products, magnets, electrical contacts, and electrodes, as
well as surgical and dental prostheses (National Toxicology Pro-
gram, 2005). Nickel occurs at very low levels in the environment,
although it is ubiquitous in air, water, and food. Environmental
exposure occurs through inhalation, ingestion, and dermal con-
tact. The general population takes in the most nickel via food,
but exposure also can occur via tobacco smoke and nickel-plated
materials such as coins, steel, and jewelry (National Toxicology
Program, 2005).
The mechanisms of nickel carcinogenesis remain unclear. Sev-
eral studies have suggested that chromatin structural alterations
and epigenetic changes play a role in nickel carcinogenesis (Sal-
nikow and Zhitkovich, 2008). DNA hypermethylation leading to
inactivation of gpt expression was found in Chinese hamster G12
cells (Lee et al., 1995). In addition, hypermethylation in the pro-
moter region of tumor suppressor gene p16 was found in tumors
of wild-typeC57BL/6mice heterozygous for tumor suppressor p53
implanted with nickel sulﬁde (Govindarajan et al., 2002). Nickel
also has been shown to exert its effect on gene silencing by mech-
anisms that involve changes in histone acetylation. For example,
nickel-induced gene silencing resulted from H4 and H3 histone
acetylation and methylation of lysine 9 in histone H3 in the gpt
transgenic cell line of Chinese hamsters (Yan et al., 2003). Nickel
has also been shown to lead to the deacetylation of H4 in vitro
(Broday et al., 2000). Nickel chloride was found to decrease the
histone acetylation of H2A, H2B, H3, and H4 and increase the
histone ubiquitination of H2A and H2B (Ke et al., 2006). These
data suggest that epigenetic changes contribute to nickel-induced
carcinogenic effects. However, population studies are needed to
determine if these effects are observed in humans.
CHROMIUM
Chromium has been established to be an essential trace element
in mammals in regard to maintenance of normal carbohydrate
metabolism. Chromium(III) is found in moderate amounts in a
wide range of foods, such as egg yolks, whole grain, high-bran
cereals, nuts, green beans, broccoli, meat, brewer’s yeast, wine,
and beer; Anderson and Kozlovsky, 1985). As a dietary supple-
ment, chromium is available in many multivitamin and mineral
products.However, the role of chromium supplementation among
subjects with normal diet is still controversial (Wang and Cefalu,
2010). People should also be aware of the formof chromiumprod-
ucts presented. Hexavalent chromium [Cr(VI)] compounds are
carcinogenic to humans (IARC, 1990; National Toxicology Pro-
gram, 2005). Cr(VI) is used in the production of stainless steel and
pressure-treated wood. The general population may be exposed to
Cr(VI) compounds by inhalation, ingestion of water, or dermal
contact with products that contain Cr(VI) (National Toxicology
Program, 2005). Epidemiologic studies investigating the risk of
lung cancer in occupational settings that manufacture chromate
products have been consistently demonstrated the relationship
between Cr(VI) exposure and lung cancer (Gibb et al., 2000;
National Toxicology Program, 2005). Mechanisms of Cr(VI) car-
cinogenesis are poorly understood. It is believed that Cr(VI) can
exert its carcinogenic effect via oxidative stress and DNA damage
associated with Cr-DNA adducts, protein–DNA crosslinks, and
DNA single- and double-strand breaks (Sugden and Stearns, 2000;
Bagchi et al., 2001; Shi et al., 2004; Zhitkovich, 2005). Interest is
increasing in Cr(VI)-induced epigenetic changes as a potential
carcinogenic mechanism. Indeed, both animal and human studies
have shown some evidence of changes in epigenetic marks asso-
ciated with Cr(VI) exposure. Potassium chromate salts induced
aberrant DNA methylation silencing the G12 reporter transgene
in Chinese hamster lung cells (Klein et al., 2002). Chromate also
was shown to be associated with histone modiﬁcation. Chromate
signiﬁcantly increased tri-methyl H3K4 after exposure in human
lung carcinoma A549 cells (Zhou et al., 2009). In human lung
tumors, hypermethylation of the p16 promoter region was found
in Japanese workers exposed to Cr(VI); the effect was time- and
dose-speciﬁc (Kondo et al., 2006). Also among these workers, the
DNA mismatch repair gene hMLH1 was hypermethylated, leading
to the repression of the hMLH1 protein (Sun et al., 2009).
MERCURY
Mercury (Hg) is found naturally in the environment or is emitted
into the atmosphere via industrial processes and fuel combustion.
www.frontiersin.org January 2012 | Volume 2 | Article 91 | 7
Su et al. Dietary intake and cancer epigenetics
Mercury is released into the atmosphere either as elemental mer-
cury, particle-bound mercury, or oxidized mercury (EPA, 2010).
Mercury in the atmosphere can reach aquatic environments and
be converted into methylmercury (MeHg) by sediment bacteria
(Borchers et al., 2010). Once MeHg enters the food chain, it is
absorbed by ﬁsh and shellﬁsh at toxic levels. MeHg bioaccumu-
lates progressively with each level of increase in the aquatic food
chain, from phytoplankton to predatory ﬁsh. Thus, mercury lev-
els in ﬁsh vary, with ﬁsh on the top trophic levels containing
the highest levels of MeHg (EPA, 2010). Shark, swordﬁsh, king
mackerel, and tileﬁsh contain the highest levels of MeHg, and
shrimp, salmon, pollock, and catﬁsh have the lowest levels (FDA
U.S. Food and Drug Administration, 2009). MeHg exposure in
humans occurs when seafood containing it is consumed. Con-
troversy has arisen because pregnant women have been advised
to consume ﬁsh for omega-3 fatty acids and other nutrients that
are beneﬁcial to the developing fetus, but also are being warned
to limit their consumption of mercury because of possible dam-
age to the fetal nervous system. There were speculation whether
mercury causes epigenetic modiﬁcation (Callaghan et al., 2011;
Rooney,2011).However, little evidence to support the notionuntil
a recent publication byArai et al. (2011). The investigators studied
the effects of mercury and a few other chemicals onmorphological
changes inheterochromatin andDNAmethylation status inmouse
ES cells. This study found that mercury affected heterochromatin
conditions and caused aberrant DNA methylation at gene loci.
Additionally, mercury-exposed cells also exhibited impaired for-
mation of the embryoid body, suggesting mercury as a potential
epigenetic mutagen. Additional studies may be needed to further
conﬁrm the ﬁndings.
ENDOCRINE DISRUPTORS
Endocrine disruptors are compounds found in the environment
that mimic the actions of hormones. They are ubiquitous in the
environment and have been associated with changes in epige-
netic marks following in utero and adult exposure, and these
changes may be transmitted to subsequent generations through
the germline (Li et al., 2003). Diethylstilbestrol (DES) is a synthetic
non-steroidal estrogen that is a known human carcinogen. It was
prescribed to pregnant women between 1947 and 1971 to reduce
the risk of miscarriage (National Toxicology Program, 2005). In a
ﬁnding that usually has beenobserved amongolderwomen, female
offspring of mothers exposed to DES experienced a higher risk of
clear-cell adenocarcinoma of the vagina or cervix at younger ages
(Herbst et al., 1977). DES has been shown to increase expression
of the c-fos proto-oncogene and signiﬁcantly reduce methylation
in mice exposed in utero (Li et al., 2003). Recent studies have
shown that in utero exposure to DES caused hypermethylation of
HOXA10, which is expressed in uterine epithelial and stromal cells
(Bromer et al., 2010) and directs embryonic uterine development;
DNMT1 and DNMT3b also were overexpressed (Bromer et al.,
2009). DES increased histone H3 trimethylation in human cells
and in mice exposed in utero (Doherty et al., 2010).
Food is a major source of exposure to endocrine-disrupting
chemicals such as phthalates and bisphenol A (BPA). BPA is a
known endocrine disruptor; however, its method of carcinogenic-
ity in humans is not classiﬁed. BPA is used in the production of
polycarbonate plastics and epoxy resins. Because of its pervasive
use in plastics, it is ubiquitous in the environment. Although the
available evidence does not suggest that BPA is carcinogenic on
its own, evidence indicates that it increases cancer susceptibility
through developmental reprogramming as a result of epigenetic
changes (Keri et al., 2007). Similar toDES,BPAhas been associated
with epigenetic alterations following exposure in utero (Ho et al.,
2006). For example, exposing pregnant mice to BPA produced
alterations in HOXA10 expression associated with signiﬁcantly
reduced methylation in offspring, but this reduced methylation
was not due to repression of DNMTs (Bromer et al., 2010). BPA
exposure in utero also has been shown to alter expression of EZH2
in mammary tissue. Overexpression of EZH2 is associated with
human breast cancer and reduced expression of DNA repair medi-
ators (Doherty et al., 2010). Also similar to DES, BPA increased H3
trimethylation inhumanMCF-7 cells and inmice exposed in utero.
These epigenetic changes persisted into adulthood (Doherty et al.,
2010). In themale rat, hypomethylation of PDE4D4 in the prostate
tumors of male rats was observed after neonatal BPA exposure;
these epigenetic changes appeared to be permanent (Ho et al.,
2006). BPA is present at low but detectable levels among pre-
adolescent and adolescent males and females (Wolff et al., 2006;
Calafat et al., 2007). Although such epigenetic changes have not yet
been studied in humans, these data provide compelling evidence
to suggest that exposure to BPA early in life may predispose the
mammary andprostate glands to preneoplastic lesions in adult life.
CONCLUSION
Epigenetic mechanisms have been implicated in critical processes,
such as gametogenesis, fetal development, and maintenance of
early established patterns of gene expression throughout life.
The epigenetic information carried by various epigenetic events
reviewed earlier, such as DNA methylation and histone modiﬁca-
tions, appears to be inﬂuenced signiﬁcantly by dietary and envi-
ronmental factors. The phenomenon may explain how maternal
diets and exposure to exogenous agents, such as diethylstilbestrol
(Newbold et al., 2006), can have long consequences on the health
and disease risk of the offspring. Both epidemiological data and
animal experiments support the hypothesis that diet and environ-
mental toxicants may exert their oncogenic effects through epi-
genetic as well as genetic mechanisms. The relationship between
cancer and both nutritional factors and environmental toxicants
also can be modulated either synergistically or antagonistically
by epigenetic mechanisms. A synergistic mechanism may exist
between deﬁciencies of essential nutrients and exposure to envi-
ronmental toxicants. There may also be interactions between food
and environmental toxicants that may increase the harmful effects
of the toxicants (Mahaffey and Vanderveen, 1979). Many children
and adults are experiencing a double burden of nutrient deﬁcien-
cies and exposure to environmental toxicants such as heavy metals
(Grandjean and Landrigan, 2006; Kordas et al., 2007; Wasserman
et al., 2008). Nutrients could also play a role in attenuating the tox-
icity of environmental toxicants such as polychlorinated biphenyls
(PCBs), BPA, lead, and arsenic.
The role epigenetics remain to be fully characterized in nor-
mal tissue and cancer. One of the major developments in the
ﬁeld of cancer epigenetics during the past decade has been
the rapid advance in genome-wide technologies that initially
employed microarrays but increasingly are using high-throughput
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sequencing. In the foreseeable future, cancer epigenomic meth-
ods will be able to sufﬁciently address issues of tissue hetero-
geneity and the often limiting amount of DNA present in epi-
demiologic study samples. Nevertheless, methylation proﬁling of
human cancer has revealed tissue speciﬁc epigenetic signatures,
as well as tumor speciﬁc signatures, reﬂecting the presence of
epigenetic instability of a subset of cancers affected by the CpG
island methylator phenotype (Toyota and Issa, 2005). It has been
suggested that methylation patterns can be traced to a tissue
speciﬁc, proliferation-dependent accumulation of aberrant pro-
motor methylation in aging tissues, which can be modulated by
chronic inﬂammation and less well-deﬁned mechanism such as
diet, environment, and genetic predisposition. Therefore, chal-
lenges remained in applying appropriate epigenetic techniques on
appropriate human specimens to interpret the ﬁndings. Addition-
ally, despite signiﬁcant amounts of data available on the effect
of diet on DNA methylation, less knowledge is available on the
involvement of histone modiﬁcations in the regulation of chro-
matin structure, gene expression, and identiﬁcation of the nature
of metabolic pathways that are controlled by nutrition through
epigenetic mechanisms, both in early life and adulthood. The
relationship between epigenetic events and the latent nature of
cancer in humans may also need to be more carefully explored
through prospective cohort study designs with multiple measure-
ments of diet and biomarkers during critical time points in life.
A paradigm shift with a focus on improving knowledge of the
interplay between diet and environmental toxicant exposures and
epigenetics could move the ﬁeld of modiﬁable risk factors and
cancer into an era of targeted lifestyle modiﬁcation for cancer
prevention.
In addition to the technological challenges, until recently, there
have been difﬁculties in studying the interactions between dietary
factors and environmental toxicants to understand epigenetic
mechanisms. BPA exposure levels during early development was
fund in animal study to be able to modify epigenome and increase
disease susceptibility throughout life (Dolinoy et al., 2007). It is
also found that certain nutrients such as folic acid and genis-
tein may counteract the effects of BPA. Maternal supplementation
with folic acid or the phytoestrogen genistein can decrease the
hypomethylating effect of BPA (Dolinoy et al., 2007). The ﬁnd-
ings that that BPA can alter the epigenomes of offspring but
maternal dietary supplements may counteract these effects offer a
renewed hope afﬁrming the hypotheses by Doll and Peto (1981)
that carcinogenesis may be reversible through dietary modiﬁca-
tion. To date, few epidemiologic studies have examined the effect
of nutrients or bioactive food component intakes on epigenetics
and their modulating effects on cancer, even fewer examined envi-
ronmental toxicants in food and their effects Out of more than
450 grants currently funded or co-funded by the Epidemiology
and Genetics Research Program, Division of Cancer Control and
Population Sciences, National Cancer Institute, 23 research grants
(14 Research Project Grants (R01s), four Exploratory/Research
Development Grant (R21), and ﬁve Small Grant (R03) are directly
or indirectly examining the link between epigenetic effects on
cancer in humans. Among these funded applications, only four
of them focus on the effect of dietary and environmental tox-
icants. It is obviously an under-representative area in terms of
the Epidemiology and Genetic Research Program funding. Addi-
tional epidemiologic research is needed to clarify the relationship
between these complex epigenetic mechanisms and cancer.
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